Evidence map›Paper›PMID 25483955›Full record

Observational studyAIDS care2015

Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda.

Peter K Olds, Julius P Kiwanuka, Denis Nansera, Yong Huang, Peter Bacchetti, Chengshi Jin, Monica Gandhi, Jessica E Haberer

Open access · greenAbstract readComparative StudyObservational Study
In one paragraph

Observational study in AIDS care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Peter K Oldsa Department of Medicine , Harvard Medical School , Boston , MA , USA.
Julius P Kiwanuka
Denis Nansera
Yong Huang
Peter Bacchetti
Chengshi Jin
Monica Gandhi
Jessica E Haberer
University of California, San Francisco · USMbarara University of Science and Technology · UGHarvard University · USMassachusetts General Hospital · US

Funding

WOMEN'S INTERAGENCY HIV STUDY ORGANIZATION, MANAGEMENT AND COMMUNICATIONSU01AI034989 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, GREENBLATT, RUTH MARTHA · 1993 to 2018
$65.6M
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention TrialsR01AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GANDHI, MONICA · 2012 to 2021
$5.6M
“Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.R37AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2023 to 2026
$3.2M
Innovative methods for measuring antiretroviral exposureR01AI065233 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENBLATT, RUTH MARTHA · 2005 to 2010
$2.2M
Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in UgandaK23MH087228 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2009 to 2013
$916k
Measurement of adherence to ART in HIV-infected school-aged children in UgandaR21MH083306 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HABERER, JESSICA ELIZABETH · 2008 to 2009
$362k
NIAID NIH HHS 3R01AI065233-05S2NIAID NIH HHS R01 AI065233NIAID NIH HHS R01 AI098472NIAID NIH HHS R01AI098472NIAID NIH HHS R37 AI098472NIAID NIH HHS U01 AI034989NIMH NIH HHS K23 MH087228NIMH NIH HHS K23MH087228NIMH NIH HHS R21 MH083306NIMH NIH HHS R21MH083306
6 · The paper itself

Abstract

Current tools for measuring medication adherence have significant limitations, especially among pediatric populations. We conducted a prospective observational study to assess the use of antiretroviral (ARV) drug levels in hair for evaluating antiretroviral therapy (ART) adherence among HIV-infected children in rural Uganda. Three-day caregiver recall, 30-day visual analog scale (VAS), Medication Event Monitoring System (MEMS), and unannounced pill counts and liquid formulation weights (UPC) were collected monthly over a one-year period. Hair samples were collected quarterly and analyzed for nevirapine (NVP) levels, and plasma HIV RNA levels were collected every six months. Among children with at least one hair sample collected, we used univariable random intercept linear regression models to compare log transformed NVP concentrations with each adherence measure, and the child's age, sex, and CD4 count percentage (CD4%). One hundred and twenty-one children aged 2-10 years were enrolled in the study; 74 (61%) provided at least one hair sample, and the mean number of hair samples collected per child was 1.9 (standard deviation [SD] 1.0). Three-day caregiver recall, VAS, and MEMS were found to be positively associated with increasing NVP concentration in hair, although associations were not statistically significant. UPC was found to have a nonsignificant negative association with increasing hair NVP concentration. In conclusion, NVP drug concentrations in hair were found to have nonsignificant, although generally positive, associations with other adherence measures in a cohort of HIV-infected children in Uganda. Hair collection in this population proved challenging, suggesting the need for community education and buy-in with the introduction of novel methodologies.

Indexed as

Medication AdherenceRural PopulationAnti-HIV AgentsChildChild, PreschoolFemaleHairHIV InfectionsHumansLongitudinal StudiesMaleNevirapineProspective StudiesReproducibility of ResultsUgandaAnti-HIV AgentsNevirapineadherenceantiretroviral therapychildrenhuman immunodeficiency virusUganda

Identifiers

PMID25483955
PMCPMC4305465
OpenAlexW2038723027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.